Bain Capital has agreed to acquire Vitabiotics and significant parts of the wider VB Group from the Lalvani family. The Tej Lalvani vitamins business deal has been valued by reports at approximately £900 million, with some coverage rounding the figure to £1 billion. However, neither party has publicly disclosed the financial terms.
The agreement was announced on 24 July 2026 and remains subject to closing conditions and regulatory approvals. It therefore represents an agreed acquisition rather than a completed transfer of ownership. The deal marks a major change for a vitamins company that has remained under family leadership since Professor Kartar Lalvani founded it in 1971.
Key Takeaways:
- Bain Capital has agreed to acquire Vitabiotics and relevant VB Group businesses.
- The widely reported valuation is about £900 million, but no official price has been published.
- UK, Indian and African operations are included, while certain other entities remain outside the deal.
- The acquisition has not yet completed and requires regulatory approval.
- No immediate changes to day-to-day operations have been announced.
The distinction between confirmed terms and reported valuations is central to understanding the transaction.
What Has Been Agreed In The Tej Lalvani Vitamins Business Deal?
The Tej Lalvani vitamins business deal is an agreement under which Bain Capital will take control of Vitabiotics’ UK operation and specified businesses within the wider VB Group.
The official acquisition terms statement identifies Meyer Organics in India and African operations, including VB Egypt, among the businesses covered. It describes the transaction as a milestone in Vitabiotics’ 55-year history and the beginning of a planned period of accelerated international expansion.
Tej Lalvani was group chief executive when the agreement was announced. His father, Professor Kartar Lalvani, founded Vitabiotics in 1971 and developed it into a prominent British vitamins, minerals and supplements company.
Although news headlines commonly describe Lalvani as having “sold” the business, legal ownership does not transfer simply because an agreement has been signed. Completion will occur only after the required conditions have been satisfied.
How Much Is The Vitabiotics Deal Reportedly Worth?
The transaction is most consistently reported at close to £900 million. Other reports have described it as a deal worth up to £1 billion, but the difference largely reflects rounding and the absence of publicly available financial terms.
A company valuation is not necessarily the same as the amount shareholders receive. Enterprise value may account for cash, debt and other adjustments, while the final equity consideration can depend on the agreed transaction structure.
Reports have also stated that Vitabiotics’ annual global sales increased from £101 million to £195.6 million during Tej Lalvani’s leadership. On that basis, a valuation between £900 million and £1 billion would equal approximately 4.6 to 5.1 times reported annual sales. This is an editorial calculation, not an officially published transaction multiple.
The safest description is therefore a “reported £900 million acquisition”, rather than a confirmed £900 million payment to Tej Lalvani or his family.
Which Vitabiotics Businesses Are Included In The Acquisition?
The agreement extends beyond the core British trading company. However, it does not cover every entity that may be associated with the Lalvani family or use a related group identity.
Included Businesses And Regional Operations
- The announced transaction includes Vitabiotics’ UK operations, relevant parts of the wider VB Group, Meyer Organics in India and operations in Africa, including VB Egypt.
- These assets give the combined business a presence across several important vitamin and wellness markets. Vitabiotics says its products are exported to more than 70 countries, while the group has established operations in India, China, Egypt and the wider Middle East and North Africa region.
Which Businesses Remain Outside The Deal?
- The announcement states that certain group entities operating in jurisdictions outside the transaction’s scope are excluded. Those businesses are expected to continue under their existing beneficial ownership arrangements.
- This means the transaction should not be described as the sale of every Lalvani-controlled company without further evidence.
Why The Transaction Perimeter Matters?
The scope affects both future control and how the reported valuation should be interpreted.
Transaction Scope:
| Business Or Issue | Position |
| UK Vitabiotics operations | Included |
| Wider VB Group businesses | Included where specified |
| Meyer Organics in India | Included |
| African operations, including VB Egypt | Included |
| Every related international entity | Not included |
| Exact value assigned to each operation | Not disclosed |
Understanding these boundaries prevents the acquisition from being presented as broader than the confirmed agreement.
Why Has Bain Capital Agreed To Buy Vitabiotics?
Vitabiotics offers a combination of recognised brands, established retail relationships, scientific positioning and access to both mature and developing consumer markets.
The investor has identified several potential areas for expansion.
Planned Investment Priorities:
- Developing and launching new products.
- Expanding digital and e-commerce capabilities.
- Strengthening international distribution.
- Improving supply-chain resilience.
- Growing the business in India, China, Africa and the Middle East.
- Building on Vitabiotics’ existing UK market position.
Vitabiotics owns brands including Pregnacare, Perfectil, Wellman, Wellwoman, Osteocare, Menopace and the Ultra range. Its products address areas such as pregnancy, men’s and women’s health, beauty, family nutrition and different life stages.
The investor described the company as a science-led platform with consumer trust and healthcare-professional credibility. Those comments express the buyer’s strategy and expectations; they do not guarantee particular growth rates, product launches or financial results.
How Did Tej Lalvani Help Grow Vitabiotics Before The Deal?
Vitabiotics began as a British family business founded by Professor Kartar Lalvani in 1971. The public company incorporation record confirms that Vitabiotics Limited was incorporated on 25 May 1971 and remains registered as an active private company.
Tej Lalvani joined the business after university and has worked within it for more than 30 years. Accounts of his early career describe him working in the warehouse and gaining experience across different departments before progressing into senior management. His own account has included driving a forklift and moving boxes rather than entering the company immediately as chief executive.
Key Stages In His Career:
- He joined the family business after completing university.
- He gained operational experience across the company.
- He previously served as chief operating officer.
- He became chief executive in 2015.
- He oversaw product launches and international expansion.
- He appeared on Dragons’ Den between 2017 and 2021.
Reported annual global sales rose from £101 million to £195.6 million under his leadership, although detailed transaction documents and more recent complete accounts are not publicly available.
Lalvani described the agreement as “a defining moment”. He added: “This direction is not about changing who we are; it is about accelerating what we can become.”
His public profile helped make him recognisable, but Vitabiotics’ reported valuation also reflects its brands, formulations, distribution network, international operations and market position.
What Will Happen To Tej And Kartar Lalvani After The Acquisition?
The announcement provides a confirmed future position for the company’s founder but offers less detail about the long-term executive role of his son.
Kartar Lalvani’s Chairman Emeritus Role
- Professor Kartar Lalvani is expected to assume the honorary role of chairman emeritus when the transaction completes.
- The official company leadership profile identifies him as the company’s founder and explains his role in developing its science-led approach to nutritional products. The acquisition announcement also recognises his contribution to the supplements sector and the company’s development over more than five decades.
- A chairman emeritus title is generally honorary or advisory. It does not automatically mean that the holder will retain control over daily operations or corporate decisions.
Will Tej Lalvani Remain Chief Executive?
- Tej Lalvani was described as group chief executive in the transaction announcement. However, no complete post-acquisition management structure or fixed period for his continued leadership was disclosed.
- There is consequently no verified basis for saying that he has resigned, retired or permanently left the company. His longer-term role may become clearer when completion or subsequent leadership arrangements are announced.
What Could The Deal Mean For UK Employees And Customers?
The buyer has said the UK will remain central to Vitabiotics’ brand, innovation and category leadership. It has also stated that there will be no immediate changes to day-to-day operations.
That position suggests continuity during the acquisition process.
What Has Been Announced?
- Existing operations will continue serving customers, retailers and partners.
- The UK will remain important to the company’s identity and development.
- Investment is planned in innovation, technology and online sales.
- International distribution and operational capabilities are expected to expand.
- No immediate product-range or workplace changes have been specified.
The wording “no immediate changes” should still be interpreted carefully. It describes the short-term position and is not a permanent guarantee that staffing, management, manufacturing or organisational arrangements will never change.
There is also no confirmed evidence that the transaction will alter product prices, availability or formulations. Any such claim would require a separate announcement or observable change after completion.
Has Bain Capital Completed The Purchase Of Vitabiotics?
No completed transfer of ownership has been announced. The parties have reached an agreement, but the transaction remains subject to applicable closing conditions and customary regulatory approvals.
A signed acquisition agreement establishes the terms on which a buyer intends to purchase a business. Before completion, the parties may need to secure regulatory clearance, satisfy contractual conditions and complete legal and financial procedures.
The advisers named in the announcement include Houlihan Lokey and Macfarlanes for the selling party, with Rothschild & Co and Kirkland & Ellis advising the buyer. Indian legal matters were handled with additional local counsel.
Until a formal closing announcement is issued, wording such as “agreed to acquire” or “planned takeover” remains more precise than stating that the purchase is complete.
Why Does The Tej Lalvani Vitamins Business Deal Matter?
The transaction is significant because it moves a long-established British family business towards ownership by a global private investment group. It also connects an established UK brand portfolio with a buyer seeking growth across several international markets.
Private Equity Interest In Health And Wellness Brands
Vitamin and wellness businesses can attract investment when they combine repeat consumer demand with recognised products and established distribution.
Vitabiotics presents several such features:
- A portfolio spanning multiple health needs and life stages.
- Brands sold through established retail and pharmacy channels.
- Exports to more than 70 countries.
- Operations in the UK and high-growth international markets.
- A history of product development and scientific positioning.
These factors offer potential routes for expansion, although future performance will depend on execution, competition, regulation and consumer demand.
What Does The Reported Valuation Signal?
A valuation approaching £900 million suggests that the buyer may place substantial value on Vitabiotics’ brand recognition, product portfolio, intellectual property, international distribution and growth prospects.
The reported figure should not, however, be interpreted as Tej Lalvani’s personal proceeds. The family’s eventual return would depend on ownership percentages, liabilities, transaction expenses, taxes and the confidential structure of the agreement.
The Wider UK Business Context
The deal illustrates how a British company can become attractive to international investors by combining domestic market leadership with overseas reach.
It also ends, subject to completion, more than five decades in which Vitabiotics developed under the Lalvani family. Bain’s Asia-based investment team is leading the transaction, reflecting the strategic importance of India, China and other international markets alongside the company’s British base.
The agreement is therefore both an ownership transition and a proposed platform for further international expansion.
Conclusion
The Tej Lalvani vitamins business deal will transfer Vitabiotics and specified VB Group operations to Bain Capital if its closing conditions and regulatory requirements are satisfied. Although reports value the acquisition at around £900 million to £1 billion, the official purchase price remains undisclosed.
The agreement represents a major change for a family-founded British company that has operated since 1971. Key unanswered questions include the final completion date, the confidential financial structure and Tej Lalvani’s longer-term management role.
Frequently Asked Questions
When Was Vitabiotics Founded?
Vitabiotics was founded in 1971 by scientist and entrepreneur Professor Kartar Lalvani. The UK company was incorporated on 25 May of that year.
Which Product Brands Are Best Known?
Its portfolio includes Pregnacare, Wellman, Wellwoman, Perfectil, Menopace and Osteocare. These brands cover pregnancy, beauty, family nutrition and different age or life-stage needs.
What Kind Of Investor Is Bain Capital?
Bain Capital is a global private investment firm operating across private equity, credit, growth investment and real assets. It reported approximately $225 billion in assets under management in its acquisition announcement.
How Long Did Tej Lalvani Appear On Dragons’ Den?
Tej Lalvani appeared on the BBC business programme from 2017 until 2021. His final series aired before Steven Bartlett joined the investor line-up.
Could The Reported £900 Million Value Change?
Yes, because the financial terms have not been officially disclosed. Final consideration may differ from reported valuation estimates because of debt, cash, adjustments or other transaction terms.
Will Products Remain Available In Britain?
No immediate operational or availability changes have been announced. Long-term product and distribution decisions will remain matters for the company after completion.
Where Will Further Transaction Updates Appear?
Further details are likely to be published through formal company statements and relevant regulatory records. A completion announcement would provide the clearest confirmation that ownership has legally transferred.
Note: The £900 million and £1 billion figures are media-reported estimates rather than an officially disclosed purchase price. The acquisition should not be described as completed until the parties confirm that all closing conditions and regulatory requirements have been satisfied.